Prostate cancer: AR aberrations and resistance to abiraterone or enzalutamide

Gerhardt Attard; Emmanuel S. Antonarakis

doi:10.1038/nrurol.2016.212

Prostate cancer: AR aberrations and resistance to abiraterone or enzalutamide

Gerhardt Attard, Emmanuel S. Antonarakis

Research output: Contribution to journal › Short survey › peer-review

Original language	English (US)
Pages (from-to)	697-698
Number of pages	2
Journal	Nature Reviews Urology
Volume	13
Issue number	12
DOIs	https://doi.org/10.1038/nrurol.2016.212
State	Published - Dec 1 2016
Externally published	Yes

ASJC Scopus subject areas

Urology

Access to Document

10.1038/nrurol.2016.212

Cite this

@article{e000df97143741e583f47b7122d60270,

title = "Prostate cancer: AR aberrations and resistance to abiraterone or enzalutamide",

author = "Gerhardt Attard and Antonarakis, {Emmanuel S.}",

year = "2016",

month = dec,

day = "1",

doi = "10.1038/nrurol.2016.212",

language = "English (US)",

volume = "13",

pages = "697--698",

journal = "Nature Reviews Urology",

issn = "1759-4812",

publisher = "Nature Publishing Group",

number = "12",

}

TY - JOUR

T1 - Prostate cancer

T2 - AR aberrations and resistance to abiraterone or enzalutamide

AU - Attard, Gerhardt

AU - Antonarakis, Emmanuel S.

PY - 2016/12/1

Y1 - 2016/12/1

UR - http://www.scopus.com/inward/record.url?scp=84994129947&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994129947&partnerID=8YFLogxK

U2 - 10.1038/nrurol.2016.212

DO - 10.1038/nrurol.2016.212

M3 - Short survey

C2 - 27804988

AN - SCOPUS:84994129947

SN - 1759-4812

VL - 13

SP - 697

EP - 698

JO - Nature Reviews Urology

JF - Nature Reviews Urology

IS - 12

ER -

Prostate cancer: AR aberrations and resistance to abiraterone or enzalutamide

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this